Founded | 2006 |
---|---|
Founders | France, Brazil, Chile, Norway and the United Kingdom |
Focus | HIV/AIDS, Malaria, Tuberculosis |
Location | |
Area served
|
Worldwide |
Method | Grants |
Key people
|
Lelio Marmora, Executive Director Celso Amorim, former Foreign Minister of Brazil and Chair of UNITAID Philippe Douste-Blazy, former French Foreign Minister and founding Chair of UNITAID |
Revenue
|
$2.4 billion between 2007 and 2014, 62% of which has been raised through a solidarity levy on airline tickets |
Website | www.unitaid.org |
UNITAID is a global health initiative in great part financed by a solidarity levy on airline tickets. Established in 2006 by the governments of Brazil, Chile, France, Norway and the United Kingdom, it provides sustainable funding in order to tackle inefficiencies in markets for medicines, diagnostics and prevention for HIV/AIDS, Malaria and Tuberculosis in developing countries.
Hosted by the WHO in Geneva, the organization's principal strength is the negotiation of low prices for drugs and diagnostics on the basis of its strong financial means. UNITAID does not have its own programs for the distribution of medication but supports programs by its implementer organizations such as the Clinton Health Access Initiative,The Global Fund, the Stop TB Partnership of the WHO, Médecins Sans Frontières,TB Alliance, the Medicines for Malaria Venture and others.
Due to a growing number of Member States (29 as of 2008) UNITAID's revenue has exceeded US2.4 billion through 2014 out of which at least 85% must be distributed to low-income countries.
The political actions towards the establishment of UNITAID had been preceded by two major reports on innovative financing: The Report of the Technical Group on Innovative Financing Mechanisms was formulated upon request by the Heads of State of Brazil, Chile, France and Spain and was published in September 2004; the Landau-report originated in a request by French President Jacques Chirac and was issued in December 2004. Both documents present various opportunities for innovative financing mechanisms while equally stressing the advantages (stability and predictability) of tax-based models.